Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
02-07

For the quarter ended December 2024, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, down 2.1% over the same period last year. EPS came in at $0.27, compared to $0.25 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.71 billion, representing a surprise of -1.45%. The company delivered an EPS surprise of +8.00%, with the consensus EPS estimate being $0.25.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Avantor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Bioscience Production: $560.80 million versus $563.83 million estimated by four analysts on average.
  • Revenue- Laboratory Solutions: $1.13 billion versus the four-analyst average estimate of $1.16 billion.
  • Adjusted Operating Income- Laboratory Solutions: $147.40 million compared to the $147.52 million average estimate based on two analysts.
  • Adjusted Operating Income- Corporate: -$17.20 million versus -$16.03 million estimated by two analysts on average.
  • Adjusted Operating Income- Bioscience Production: $149.20 million compared to the $139.91 million average estimate based on two analysts.
View all Key Company Metrics for Avantor here>>>

Shares of Avantor have returned -1.9% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Avantor, Inc. (AVTR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10